Blood urea nitrogen to creatinine ratio and long-term survival in patients with chronic heart failure

Yajiao Wang1, Xia Xu1, Shuqing Shi1

  • 1Guang 'anmen Hospital, Chinese Academy of Traditional Chinese Medicine, Beijing, China.

PubMed

Insights

The Blood urea nitrogen to creatinine ratio (BUN/Scr ratio) is linked to worse outcomes in patients with chronic heart failure (CHF) and kidney injury. A higher BUN/Scr ratio independently predicts a greater risk of all-cause death in these patients.

Area of Science:

  • Cardiology
  • Nephrology
  • Clinical Prognostics

Background:

  • Chronic heart failure (CHF) is a complex condition often complicated by renal injury.
  • Assessing prognostic markers in CHF patients with renal impairment is crucial for improving patient outcomes.

Purpose of the Study:

  • To investigate the association between the Blood urea nitrogen to creatinine ratio (BUN/Scr ratio) and the prognosis of patients with chronic heart failure (CHF) complicated by renal injury.

Main Methods:

  • A retrospective analysis of 504 CHF patients with renal injury was conducted.
  • The optimal cutoff value for the BUN/Scr ratio was determined using ROC analysis (19.37).
  • Patients were categorized into two groups (BUN/Scr < 19.37 and BUN/Scr ≥ 19.37) for survival analysis using Kaplan-Meier curves and Cox regression.

Main Results:

  • Patients with a BUN/Scr ratio ≥ 19.37 exhibited a significantly higher mortality rate compared to those with a ratio < 19.37.
  • Multivariate analysis revealed that a BUN/Scr ratio ≥ 19.37 was an independent predictor of all-cause death (HR = 1.885, P = 0.001).
  • Subgroup analyses indicated that NYHA class and estimated glomerular filtration rate (eGRF) influenced the relationship between BUN/Scr ratio and CHF prognosis.

Conclusions:

  • The BUN/Scr ratio is significantly associated with poor prognosis in patients with CHF and renal injury.
  • The BUN/Scr ratio serves as an independent predictor of all-cause mortality in this patient population.
  • Clinical factors like NYHA class and eGRF may modify the prognostic value of the BUN/Scr ratio.
Abstract

Related Concept Videos

Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
23
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
119
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
41
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
115
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
118
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16